Biopharmaceutical Analysis eBook
Read the article:
Improving IR Spectroscopy as a Tool for Biopharmaceutical Analysis
Read the ebook:
BioPharm International’s Biopharmaceutical Analysis eBook
Microfluidic Modulation Spectroscopy is a recent innovation in infrared spectroscopy techniques that improves elucidation of secondary protein structure.
Robert Kneschke/stock.adobe.com
Over the past two decades, the biopharmaceutical industry, along with the associated regulatory authorities and analytical instrument suppliers, have progressed toward clearer identification of the attributes that are critical for ensuring the quality of biopharmaceuticals and how to measure them efficiently.
The need to understand and predict these molecules’ behavior drives a requirement for new informational insights. This article puts the spotlight on infrared spectroscopy and recent innovations, including the introduction of Microfluidic Modulation Spectroscopy.
Read the article:
Improving IR Spectroscopy as a Tool for Biopharmaceutical Analysis
Read the ebook:
BioPharm International’s Biopharmaceutical Analysis eBook
Read this article in BioPharm International’s July 2021 Biopharmaceutical Analysis eBook.
Holly Lombardo*, HLombardo@redshiftbio.com, is product manager, and Matthew McGann is marketing manager; both are at RedShiftBio.
*To whom all correspondence should be addressed.
BioPharm International
eBook: Biopharmaceutical Analysis, July 2021
July 2021
Pages: 31–34
When referring to this article, please cite it as H. Lombardo and M. McGann, “Improving IR Spectroscopy as a Tool for Biopharmaceutical Analysis," BioPharm International Biopharmaceutical Analysis eBook (July 2021).
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Mechanistic Hypothesis of Toxicity: Driving Decision Making in Preclinical Translation
August 2nd 2025Mechanistic toxicity hypothesis is essential in guiding decision-making and predicting toxicities during the preclinical stages of drug development. The authors highlight the growing importance of integrating advanced technologies like mass spectrometry imaging into toxicology to enhance preclinical translation, foster innovation in therapeutic development, and ultimately improve drug safety and efficacy.